Reading the graph
Private Equity
New York, NY
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures, news and newswire. Page built and rebuilt at most every 15 minutes.
Dated 2026-08-06 (document); first seen by DFX 2026-09-15.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| Maroon Investors, LP | 2024 | Unknown | Private Equity Fund | n/a | $265M | 0 |
| Windrose Health Investors Vi-A, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $690M | 0 |
| Windrose Health Investors VI, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $894M | 0 |
| Windrose Health Investors V-A L.P. | 2018 | Unknown | Private Equity Fund | n/a | $287M | 0 |
| Windrose Health Investors V L.P. | 2018 | Unknown | Private Equity Fund | n/a | $753M | 0 |
| MTS Health Investors IV, L.P. | 2017 | Harvest | Private Equity Fund | n/a | $289M | 0 |
| MTS Health Investors Executive IV, L.P. | 2017 | Harvest | Private Equity Fund | n/a | $2.1M | 0 |
| MTS Celerion Holdings, LLC. | 2015 | Wound down | Private Equity Fund | n/a | $49.0M | 0 |
| MTS Anesthesia LLC | 2014 | Wound down | Private Equity Fund | n/a | $428,368 | 0 |
| Ddds Mts LLC | 2013 | Wound down | Private Equity Fund | n/a | $240,387 | 0 |
| Woodbury Co-Investment, LLC | 2013 | Wound down | Private Equity Fund | n/a | $9.9M | 0 |
| Mts-Aerocare | 2013 | Wound down | Private Equity Fund | n/a | $251,147 | 0 |
| MTS Health Investors III, L.P. | 2013 | Harvest | Private Equity Fund | n/a | $38.6M | 0 |
| MTS Investors D, LP | n/a | Wound down | Private Equity Fund | n/a | $217,036 | 0 |
| MTS Investors, LP | n/a | Wound down | Private Equity Fund | n/a | $477,648 | 0 |
| MTS Investors C, LP | n/a | Wound down | Private Equity Fund | n/a | $306,709 | 0 |
| MTS Health Investors II, LP | n/a | Wound down | Private Equity Fund | n/a | $1.6M | 0 |
| Windrose Health Investors Oversubscribed Fund VII | n/a | Unknown | n/a | n/a | n/a | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Verified Clinical Trials, LLC | n/a | platform | control | Aug 6, 2026 | n/a | active |
| Avalon Healthcare Solutions | n/a | unknown | unknown | Jan 12, 2026 | n/a | active |
| Altruix | Md | unknown | unknown | n/a | May 28, 2026 | exited |
| BPD Healthcare | n/a | unknown | unknown | n/a | Oct 22, 2025 | exited |
Also named here, with no published line of their own (reach them through the firm): David Moore Pontius (Partner), Christopher Joseph Burnes (Partner), Oliver Taft Moses (Managing Partner), Alexander Buzik (Partner), Michael Jason Spiciarich (Cco).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan